Preclinical testing of a vaccine candidate against tularemia. - Wikidata - wikimedia - TriplyDB

Preclinical testing of a vaccine candidate against tularemia.

Preclinical testing of a vaccine candidate against tularemia.

http://www.wikidata.org/entity/Q35513176

about

Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.Tularemia vaccine development: paralysis or progress?Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.

P2860

Q35670540-11531B62-37C4-4199-A1FE-76E4E14286C9 Q36908692-C597947A-9E7D-41B9-A7B7-8B9AD9870DEC Q55070411-19F16A83-A95D-448C-A6BA-BB5B0CCFDD4D

P2860

Preclinical testing of a vaccine candidate against tularemia.

http://www.wikidata.org/entity/Q35513176

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Preclinical testing of a vaccine candidate against tularemia.

@ast

Preclinical testing of a vaccine candidate against tularemia.

@en

type

label

Preclinical testing of a vaccine candidate against tularemia.

@ast

Preclinical testing of a vaccine candidate against tularemia.

@en

prefLabel

Preclinical testing of a vaccine candidate against tularemia.

@ast

Preclinical testing of a vaccine candidate against tularemia.

@en

P1433

Q35513176-B03DE5EF-0C55-4D6A-A1DC-95677E144345

P1476

Q35513176-653A787C-106D-4C0A-8A2E-B704554A8281

P2093

Q35513176-00500C25-ABDC-4A7C-A2A8-A602E36CA764

Q35513176-2636146D-BEF1-410C-99E4-7E432CD9D453

Q35513176-54FAF7A8-81CC-4ABA-B0DD-AEB5C569DBF1

Q35513176-B141566B-F6F4-4F96-B9D7-E8BAA665CD60

Q35513176-B4AF1FC3-E2AE-4537-AF17-28D2EABFFF22

Q35513176-B9005478-9AC1-4603-9FEC-90A1AF7B40F4

Q35513176-BBFD4440-7DE7-4A8A-91EA-0C6C15DA879E

Q35513176-E5658549-9B0E-4E86-B9A0-21CC539DCFCC

P2860

Q35513176-00BE8A3E-D60D-436B-9C20-8828F3C7F408

Q35513176-05A3B0A0-2E76-41CB-A2ED-31C9B83C1031

Q35513176-06E4E5AF-6426-4C4A-98EB-9F4D08CB5AEF

Q35513176-0BE74CC4-2C25-4417-B3F0-675AD844C6BB

Q35513176-0CEC7945-4E0F-442B-A909-28A3BA7F83E2

Q35513176-2207C799-4077-45BB-A0AE-EC83E102D4DC

Q35513176-31CC6283-16FD-4D84-B8B1-7A3EE7274A66

Q35513176-43CF8DCA-327F-4E25-B751-673D51512DA9

Q35513176-5268B5E8-DA54-4ED3-B68D-4835E4837B69

Q35513176-541146B6-FF7C-4B2B-AD63-1FB6F56703EB

P304

Q35513176-6B7B28EC-4628-40B7-AC56-1657083B6ACB

P31

Q35513176-974C93AF-0974-4244-8DA3-7D42718FE999

P356

Q35513176-1B507B42-6848-49F4-8459-B6C8D186A3EC

P407

Q35513176-6B719EC6-AE31-4458-99A7-176022E23709

P433

Q35513176-683CB0F5-0745-4215-BCF7-C2E14B9E0E21

P478

Q35513176-DC662562-206B-4DFB-B170-D57661A9D470

P50

Q35513176-2BD9BC9F-1B0C-43C4-8CE3-93D5E37B091C

P577

Q35513176-932DF666-B7B6-48A6-ABAF-F0720DAFFA25

P5875

Q35513176-12AF88C8-84BA-4306-BAC1-D3ECD5A1ADE2

P698

Q35513176-C5DE9FDB-D5A6-4DCD-8CDC-12BA7C1539CE

P932

Q35513176-249C96B4-7904-4C66-BA0E-F47D60F3C808

P356

JOURNAL.PONE.0124326

P1433

P1476

Preclinical testing of a vaccine candidate against tularemia.

@en

P2093

Chandra Shekhar Bakshi

http://www.w3.org/2001/XMLSchema#string

Edmund J Gosselin

http://www.w3.org/2001/XMLSchema#string

Ragavan Varadharajan Suresh

http://www.w3.org/2001/XMLSchema#string

Raju Sunagar

http://www.w3.org/2001/XMLSchema#string

Sally V Catlett

http://www.w3.org/2001/XMLSchema#string

Sukalyani Banik

http://www.w3.org/2001/XMLSchema#string

Vivek Bhatty

http://www.w3.org/2001/XMLSchema#string

Zhuo Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates

Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis

Signatures of T cells as correlates of immunity to Francisella tularensis

Identification of an essential Francisella tularensis subsp. tularensis virulence factor.

A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.

Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice.

Francisella tularensis antioxidants harness reactive oxygen species to restrict macrophage signaling and cytokine production

P304

e0124326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0124326

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Meenakshi Malik

P577

2015-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275342367

http://www.w3.org/2001/XMLSchema#string

P698

25897786

http://www.w3.org/2001/XMLSchema#string

P932

4405390

http://www.w3.org/2001/XMLSchema#string